Objective: To investigate the incidence and pathogenic genes of familial III degree atrioventricular block (AVB). Data and Methods: The clinical features of all members of the family were collected, including physical examination, electrocardiogram, and echocardiography. Their genes by gene sequencing and mutation analysis were detected. Results: This family contains 22 members, including six patients. The symptom began to appear in the heart at 40 years old, performing for II degree AVB, eventually developed into the III degree AVB. These six cases have been performed permanent pacemaker implantation. The genetic family chart spectrum suggested that the autosomal may not be completely dominant. Compared with normal subjects, 24 different genes were detected in patients with familial AVB. Conclusion: This family is unambiguously affected by familial AVB, and it is caused by incomplete dominant inheritance of euchromosome, and another genetic mutations may contribute to it.
introduction
Complete atrioventricular block (AVB), also known as third-degree AVB, is complete atrioventricular dissociation caused by abnormally decreased conduction ability in a part of atrioventricular conduction system, in which the impulse generated from the atrium of the heart cannot transfer down to the ventricles. AVB is caused by many causes, most of which are secondary, and more patients are over 50 years old. The familial AVB is relatively rare and mainly related to gene mutation. The current studies thought that familial AVB is divided into two types: congenital type and adult-onset type, both of which are autosomal-dominant genetic. The former is relatively uncommon and can be seen at birth or during infancy, with very poor prognosis. Moreover, the recent studies showed that it may be caused by maternal ribonucleoprotein autoantibodies. [1] For the latter, the patients have various heart block phenotypes with symptoms of various severities and most patients have an onset during 30-50 years old. The latter is an incomplete autosomal-dominant disease, susceptible to syncope or sudden death. [2] In this study, pedigree investigation of one patient with familial AVB was performed, and preliminary genetic detection and studies were performed for the pedigree, which were reported as follows.
data and mEthods

Pedigree investigation
The family members and spouse of proband were included. For the included respondents, medical histories were collected, and examinations including physical examination of conventional systems, conventional 12-lead electrocardiogram (24-h ambulatory electrocardiogram if necessary), and cardiac ultrasound were performed, and the family genetic map was drawn [ Figure 1 ]. Blood samples were collected from each included respondent and put into anticoagulant tubes, and then, DNA was extracted for genetic studies. The above procedures were all agreed by pedigree investigators, and the informed consent forms were signed. The investigation was discussed and justified by the Medical Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.
Genetic detection Sample collection
Five milliliters of venous blood was collected and put into anticoagulant tubes. The centrifuge tubes were placed in the horizontal centrifuge and then centrifuged at 3000 rpm for 20 min. After centrifugation, the mononuclear cell layer between plasma and erythrocytes was taken, and the DNA extraction of the mononuclear cells was performed. The blood genomic DNA isolation kits (TRIzol ® Reagent, Life Technologies) were used for DNA extraction, and the DNA was extracted according to the methods provided in the package insert.
Exome sequencing
Through hybridization and enrichment of exon sequences, low-quality reads were removed and quantity of reads and sequencing quality were summarized with quality control. The short sequences were mapped to the genome rapidly, redundant reads from polymerase chain reaction (PCR) amplification were removed by rmdup tool, multiple local sequence alignment was reconducted, and false positives around indel were eliminated.
Mutation analysis
The base qualities were regraded, and the bases were screened. The screened possible pathogenic gene mutation was verified by real-time PCR.
rEsults
Clinical data
The 42-year-old male proband was admitted to the hospital due to "chest tightness and palpitations for 3 days." He had chest tightness and palpitations with occasional syncope in his 30s, without special treatment. After admission in 2003, the electrocardiogram suggested second-degree AVB and pre-excitation syndrome and the ambulatory electrocardiogram showed second-degree AVB and third-degree AVB, particularly third-degree AVB. The heart echocardiography showed that the measurement values for four chambers of heart were within the normal range; thickening of interventricular septum (14 mm); left ventricular ejection fraction of 67%; decreased left ventricular diastolic compliance. After admission, xinbao pill and salbutamol sulfate were given for increasing heart rate and there was no improvement. Single chamber pacemaker implantation ventricular demand inhibited pacemaker (VVI) was performed in our hospital, and the pacemaker was changed in 2011 due to battery charge depletion.
Family history of the patient was further inquired, and it was known that other members in the family had similar disease. Therefore, other members in the family were investigated. The investigation showed six members in the family had the disease and the family pedigree is shown in Figure 1 
Mutant gene detection
The genes of patients in the family were detected by exome sequencing and the alignment with Asian healthy population was performed. Twenty-four differential genes were found, including KDELC2, SEC14 L2, SEC31A, DNAH9, EPB41 L2, RFX8, KBTBD12, KLHL29, LRRC59, LRP5, MUC6, OLFML2B, PLXNA3, KCNH6, SALL1, ARMCX4, SLC22A16, STON2, TTF1, TMEM159, UNC13B, ZNF628, ZNF699, and ZRANB2. discussion AVB is diagnosed mainly according to electrocardiogram findings, and its clinical manifestations include symptoms such as palpitations, weariness, asthenia, dizziness, and angina pectoris. The cerebral hypoperfusion can cause symptoms including syncope and confusion. In severe cases, serious consequences including heart failure and stroke can be caused. The most effective treatment is permanent pacemaker implantation. AVB has many causes, and myocardial inflammation from various causes such as rheumatic and viral myocarditis and other infections is the most common, followed by vagal excitation, adverse drug reaction, organic heart diseases, trauma, and surgery. The above causes were excluded by the pedigree investigation. In the pedigree investigation, for six patients with this disease, electrocardiogram suggested pre-excitation syndrome with AVB. Initially, it was second-degree AVB and then gradually developed into third-degree AVB, constituting the family pedigree of hereditary AVB. From pedigree analysis, hereditary transmission was continuous in the family and there were Familial AVB is very rare clinically. The age of onset for familial AVB is middle age mostly. Currently, no treatment other than pacemaker implantation for increasing heart rate is generally recognized around the world; [3] thus, the patient's quality of life is greatly reduced. Therefore, defining the pathogenesis and causes of familial AVB plays a key role in the prophylaxis and treatment. A total of six patients in the family started to have chest tightness and palpitations with syncope and heart rate of about 40 bpm before 40 and ambulatory electrocardiogram suggested bradycardia and AVB. In the family, I1, II2, II3, III2, III3, and III7 all received permanent pacemaker implantation. IV1 and IV2 are too young to have the onset. Although they have no clinical manifestations currently, as well as electrocardiogram suggested pre-excitation syndrome, and no AVB, or delayed interval or lost waves were found, future follow-up visits are needed to find out they are not in age of onset or they are healthy persons?
Previous studies reported its morbidity had a trend of familial aggregation, which suggested gene mutation. And possibly related causative genes (SCN5A, NKX2.5 and LMNA) were found in the proband and his family members. The functional expression was performed for the gene mutation and pathogenic electrophysiological mechanism was uncovered. [4] [5] [6] [7] [8] In many studies, SCN 5A gene is mainly studied. It is responsible for coding voltage-gated sodium channel type V alpha subunit and is located on 3p21-24. The gene plays an important role in rapid depolarization, conduction, and maintenance of cardiac action potential. The gene mutation can lead to change of sodium channel function and reduced sodium inflow current, resulting in slowing down and decrease in increase magnitude of action potential in depolarization phase. Therefore, excitability and conductibility of myocardial cells are reduced, resulting slowing down in cardiac conduction velocity. [9] DNA extraction from the patients in the family was performed for gene sequencing to seek mutant genes and no SCN5A-mutant genes were found, suggesting that familial AVB might be caused by other new gene mutation. Compared with normal population, the patients in the family were found to have 24 abnormal genes including KDELC2, SEC14 L2, SEC31A, DNAH9, EPB41 L2, RFX8, KBTBD12, KLHL29, LRRC59, LRP5, MUC6, OLFML2B, PLXNA3, KCNH6, SALL1, ARMCX4, SLC22A16, STON2, TTF1, TMEM159, UNC13B, ZNF628, ZNF699, and ZRANB2, which were not the same as gene sequences in normal population, but not all necessarily related to the onset of AVB, which therefore needs further demonstration by cytology experiments. Among them, KCNH6 is a potassium channel and related to the onset in the family theoretically. Its mutation increases the resting membrane potential and threshold value and decreases the excitability and conductibility of atrioventricular node or bundle branch.
Currently, there are only a small number of reports on familial AVB in China. [10] [11] [12] Its genetic studies are not clear. There are more studies on SCN5A gene mutation. The onset in the family was not caused by SCN5A gene. In recent years, with the development of molecular biology, especially the usage of patch clamp technique, mutation sites in patients in the family are further understood. These studies contribute to early diagnosis of high-risk population with hereditary susceptibility, making it easy to formulate reasonable measures of prevention and treatment, thereby providing rationale for gene treatment.
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